Our understanding of prostate cancer has changed dramatically in the last decade. It has gone from being considered a death sentence to a disease that when properly managed rarely causes life limiting problems. And while most newly diagnosed prostate cancer patients can be safely observed, a small percentage do require intervention with either surgery or radiation. A new study (http://www.europeanurology.com/article/S0302-2838(17)31031-X/fulltext) shows that the cancer control outcomes of surgery and radiation are very similar and given the significant differences in complications between those treatment modality, this is great news for many patients!
Micro Blog Articles by Henry Rosevear, MD
Urology is an ever-changing field. New medicines are discovered and new surgical procedures are created frequently. On this page, I hope to highlight some of the newest changes in urology. Please visit it frequently as I add topics constantly!
Read recent articles written by urologist, Henry Rosevear, MD of Five Roses Urology below ...
Got to go! Got to go! It seems commercials with that tag line offering medications to treat urinary urgency and frequency are becoming ever more common. And that makes sense, urinary urgency, frequency and leakage are significant problems that are incredibly undertreated. The problem, though, with these medications is that they often have side effects which most patients can’t tolerate. Other options are available and my favorite is sacral nerve modulation. A simple outpatient test can be done to see if a patient will benefit from this life changing procedure which can eliminate urinary urgency, frequency and leakage in the vast majority of patients without the side effects of medications.
Difficulty with urination from an enlarged prostate is probably the most frequent symptom I see in my clinic. An enlarged prostate can significantly reduce a patient’s quality of life. Until recently, the only options available were medications to shrink the prostate such as tamsulosin or finasteride or surgery such as a transurethral resection of the prostate (sometimes referred to as a “roto-rooter”). Recently two new minimally invasive options have become available. These include the Urolift and the Rezum. Both are less invasive options to open the prostatic channel with the potential to decrease symptoms. While the long term duration of these treatments remains unknown, I intend to watch the data closely to see if this technology should become standard of care or not.